The Board of Directors of Unitop Chemicals Private Limited, a material subsidiary of Rossari Biotech Limited, reviewed and discussed the opportunities for growth and expansion. Further, approved the capacity expansion for the subsidiary company by 18,500 MTPA in phased manner till 4th Quarter of FY 2025-26 at an outlay of Rs. 77 crores which will funded through mix of internal accruals and debt.

This project is intended to accommodate new product lines. It aligns with market demand forecasts and enhances the competitive edge in the domestic and export markets.

The Board of Directors of Tristar Intermediates Private Limited, a material subsidiary of Rossari Biotech Limited, at their meeting held on April 24, 2025, reviewed and discussed the opportunities for growth and expansion.

Further, approved the capacity expansion for the subsidiary company by adding 3,600 MTPA from its existing capacity of 15,000 MTPA which is running at 90% capacity utilization. The expansion will be carried out at an outlay of Rs. 20 crores which will be funded through mix of internal accruals and debt. The new capacity is expected to be commissioned by Q4 FY 2025-26.

The rationale behind the expansion is upgradation of existing equipment's with modern technology to improve energy efficiency, product consistency, and process safety. It will also reduce maintenance costs in long-run.